Alan H. Auerbach - Mar 3, 2022 Form 4 Insider Report for PUMA BIOTECHNOLOGY, INC. (PBYI)

Role: President and CEO, Director, 10%+ Owner
Signature: /s/ Alan H. Auerbach
Stock symbol: PBYI
Transactions as of: Mar 3, 2022
Transactions value $: $4,999,998
Form type: 4
Date filed: 3/14/2022, 07:58 PM
Previous filing: Mar 4, 2022
Next filing: Apr 5, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PBYI	Common Stock	Award	$0	+169K	+3.85%	$0.00	4.56M	Mar 3, 2022	Direct	F1
transaction	PBYI	Common Stock	Award	$5M	+1.79M	+39.34%	$2.79	6.35M	Mar 10, 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PBYI	Stock Option (Right to Buy)	Award	$0	+241K		$0.00	241K	Mar 3, 2022	Common Stock	241K	$2.33	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Subject to the Grantee's continued status as an Employee, the Restricted Stock Units shall vest with respect to one-fourth (1/4th) of the Restricted Stock Units on each of July 1, 2022, January 1, 2023, July 1, 2023 and January 1, 2024, subject to acceleration in certain events.
F2	On March 8, 2022, the Issuer entered into a Securities Purchase Agreement with certain purchasers, including the Reporting Person. Shares were purchased at $2.79 per share and issued at closing on March 10, 2022.
F3	Subject to the Optionee's continued status as an Employee, the Option shall vest and become exercisable with respect to one-fourth (1/4th) of the Shares (as defined in the Plan) subject thereto on each of July 1, 2022, January 1, 2023, July 1, 2023 and January 1, 2024, subject to acceleration in certain events.